Brazil: Ethical Aspects Of Biotechnology

Last Updated: 8 March 2013
Article by Maria Thereza Wolff

Some considerations of ETHICS are necessary for us to explore our theme properly.

Aristotle and St. Thomas of Aquino admit the existence of an absolute value, which is the supreme good, God being the ultimate goal of man.

Kant admits that the normal meaning of human acts lies in the rightness of the purposes. He states: "Act always in such a way that the principle of your action can be raised to the category of universal law".

Theobaldo Miranda Santos defines ETHICS in his Manual of Philosophy as being "the study of human action regarded as free and personal, its purpose being that of working out rules at will in his inclination to the good. It is therefore a science that deals with the use the man should make of his freedom in order to achieve his ultimate goal.

The nature of ETHICS is therefore that of a normative science, because it studies the principles that should govern human action, that is to say, man's conduct, indicating the duty which we must perform, preventing our action from being dominated by instinctive reactions, by the impulses of affection and by the sophisms of passion.

BIOTECHNOLOGY in turn, taking one of its numberless definitions, is any technological application which uses biological systems, living beings or those derived from the latter, in order to produce or modify products or processes for a specific purpose.

Combining these two themes, we now enter an extremely subjective field, namely that of the Ethical Aspects of Biotechnology, and start our work by approaching the various currents which influence these Ethical Aspects.

1. Religions

The present progress of Biotechnology has caused the Centre Universitaire de Recherches Administratives et Politiques de Picardie (France) to hold in Amiens a colloquy to debate the juridical protection of a person in the face of the biotechnological risks, the ethical aspect of the problem from the standpoint of the religions represented at said colloquy:

a) Catholicism - the new Catholicism regards as immoral the production of human embryos for exploitation as a bank of biological material, and the genetic manipulation for the purpose of selecting the sex or other characteristics of the fetus without any therapeutic purpose, because this violates the personal dignity of the human being, while the techniques of reproduction which involve a person other than the married couple, as for instance the donation of sperm or the "hired belly" are dishonest.

b) Presbyterianism - the Presbyterian Church accepts artificial insemination with a donor, provided that the child, upon being born, gets to know his genitor, but it does not admit prenatal prevention of physically disabled beings, with a strong argument, namely: how can one deem the physical disability to be intolerable from the point of view of the unborn child?

The danger of going from prevention on to the refusal of acceptance of the disabled may imply not loving ones' own child after his or she has been born.

c) Islam - Biology from the ethical standpoint of Islam presents the following situation: fertilization in vitro is a science revealed in the Eighteenth Century and, if it is carried out by the spermatozoon of the husband, it is approved. The problem of the "hired mothers" is solved by the Koran as follows: the mother's milk is equal to the blood and, since a "wet nurse" can be remunerated, a hired mother who supplies blood to the embryo and fetus can also be remunerated. The embryo will only reach the status of a human being from the 12th day on, and interrupting the gestation by a therapeutic measure is not a crime; however, euthanasia and autopsy are crimes.

d) Judaism - a Jew feels responsible for revealed law, and not for a law drawn up by humans, and the revealed law cannot be adapted to the circumstances. Man is responsible for the individuals and species. So slaughtering animals and felling plants are not crimes; but extinguishing species is a crime. In Judaism there are crimes with divine judgment and crimes with social responsibility. Abortion and euthanasia to abbreviate suffering are prohibited.

e) Buddhism - Biotechnology in the light of the Buddhist ethics states the following:

Artificial insemination is permitted, and as regards the risks BUDDHA states that obtaining the human birth is very difficult, and when the biologists reduce the difficulties of the birth, they perform an act of goodness.

2. Regulations And Rules

In several countries there are rules, recommendations and regulations in the area of genetic engineering to protect the users and their environment as far as the release of products from Biotechnology is concerned. And to creating these regulations there was not need to prevent patentability of Biotechnology, since the PATENTS refer to Industrial Property, and the USE of such products refers to the GOVENMENTAL POLICIES.

In Australia, among many regulations there is the Code of Practice of Care and Use of Animals for Scientific Experiments (1990); the Rules of genetic manipulation on a small scale (1980); the Rules for manipulation of genetically engineered organisms (1990).

In Austria there is the Act of controlled use and of intended release of genetically modified organisms in the environment (1991).

In Canada the Rules for handling recombinant DNA molecules of viruses and cells (1989) are cited.

In the USA the Governmental Regulations for the planned introductions of products from biotechnology into the environment are cited (1992); the Rules for introduction of genetically engineered plants and microorganisms (1991).

In Germany, there is the Law of Regulation of matter from Genetic Engineering (1990); the Rules of recombination in vitro of genetic material (1986); the Guidelines of Safety in Genetic Engineering; the Rules and Regulations for Safety in researches of biotechnology and production.

In France there is the Manual of practices of good research and of tests in the field of transgenic plants.

In India there are the Rules of Safety in researches of Genetic engineering and the Rules of Safety of recombinant DNA.

In Japan, the Rules for application of recombinant DNA in agriculture, in the cultivation of forest trees, in fishing, in food and in related industries.

3. Good And Evil

It is of paramount importance for us, as professionals of Industrial Property and as human beings, to have a well-defined idea of the protection of living beings, respecting our internal rules of morality and ethics, but with the knowledge and awareness of what we are assuming with this formed idea. For this purpose, we will comment some basic points of view which will be appraised here, so that each person can draw his own conclusions.

For this purpose, we will divide ourselves into two groups, one being that of the BIO-FUNDAMENTALISTS, that is, those who do not desire any change in the "status quo" and, if possible, even wish the return to the phases the preceded the changes; and the other being that of the BIO-PROGRESSISTS, who accept the changes and incorporate them in their "daily life". We will raise 6 basic questions:

Bio-Fundamentalists Immoral

1) It is immoral that Man interferes with the "Holiness of Life" and with the "Integrity of the Species", by creating genetically transformed beings which, if they spread over the face of the earth, a fact which could hardly be avoided, will modify our environment in an entirely unpredictable unknown way.

Mercantilism

2) The Scientific Community, mainly the academic researchers, in the face of the new source of revenue from patents and their licenses in biotechnology and genetic engineering, were no longer interested in publishing the results of their researches as before, but rather they began to keep them under lock and key as secrets, because "that" research might make him a millionaire through the patents. However, the pure research which has always served as a basis for applied researches is being abandoned, because it is not interesting to the researcher. Now there is a mercantilist spirit in the Universities, which is corrupting the academic world with serious consequences for the future of mankind.

Risks

3) The extent of the risks which genetically transformed plants and animals might bring to the human beings is not known. A patent unquestionably foments the researches and consequently the commercialization of genetically transformed plants and animals, with unknown results for the Planet.

Biodiversity

4) Biodiversity, which is the co-existence in nature of animals and vegetables, which have been distributed in this way over the centuries by natural selection, will be seriously threatened with unpredictable consequences for the environment and, therefore, for us human beings.

As a result of patenting living beings, enormous extents of land will be used for monoculture of genetically modified plants, which will bring more money to the holders of the respective patents with complete destruction of ecosystems.

Cartels

5) Only multinational companies and cartels, in which the economic power predominates, could research and exploit modern biotechnology and genetic engineering, thus making the division between the rich and the poor clearer and clearer.

Riches And Of Emerging Countries

6) Due to the advent of patents in the sector of plants and medicaments, the tropical forests, which are the great riches of emerging countries, will be patented, the emerging populations having to pay "royalties" for using their own property.

Bio-Progressists Immoral

1) Always, in every area, new customs were hardly accepted in the beginning, and history is there to prove this!

Today, the Societies are considering it "normal" that Man interferes with the "Holiness of Life" and with the "Integrity of the Species", by creating genetically transformed beings. Tomorrow, these being genetically transformed by inserting, for instance, a new bone marrow, will be cured of cancer or of their genetic tendency to contracting Alzheimer's disease, and then this sector of Biotechnology will no longer be considered "immoral".

Said "immorality" is therefore more a psychological problem than a matter relating to Industrial Property.

As to our environment, and its transformations caused by genetically transformed beings, they are possible, just as this transformation is possibly by burning vegetation and forest fire, prospecting and mining activities, felling tries with sawing machines and predatory fishing.

Mercantilism

2) The mercantilist spirit of the present university milieu is beneficial in a sense, because it enables the Universities not to be supported exclusively by the governments or by donations, and so the number of researchers can be greatly increased due to the financial return of the investments through patents and their licenses. In addition, a patent discloses knowledge by its compulsory publication.

Risks

3) The risks to which Mankind is subjected by the existence of genetically modified plants and animals will be irreversibly present, since the researches will continue to be made and genetically transformed beings might be set free in nature, as the case may be.

Therefore, it is not the patent that promotes or does not promote the release of these beings, but rather the governmental regulations, for instance, the Biosafety Laws will guide this release.

Biodiversity

4) The Biodiversity of the Planet is already threatened anyway, not to say in an advanced state of deterioration. Monoculture, monobreeding, the use of toxic agents released into the atmosphere, the pollution of rivers and seas, all of our ecosystem has already lost much of its diversity, independently of patents in the biotechnological area.

On the contrary, patents can even restore some of what has been destroyed, by the creation, for instance, of genetically transformed bacteria, which eliminate oil stains, plants resistant to noxious weeds, animals resistant to determined diseases, for instance, genetically transformed rats that nowadays allow tests to be carried out for fighting diseases.

Cartels

5) Poor and rich will always exist on the Earth, since the existence of different individualities is inherent in the human being. This is homodiversity! That the rich exploit the biodiversity and the genetic engineering and thereby supply the poor with means for fighting noxious weeds and diseases is already an enormous advance with respect to the so-called economic unbalance.

By the way, the history of Mankind has shown that these references "rich" and "poor" are highly variable, and whole civilizations that were formerly called "rich" Disappeared And Gave Rise To Other Civilizations That Called "Poor" Today.

Riches Of Emerging Countries

6) The tropical forests, the greatest riches of determined emerging countries, can never be patented, merely because the plants existing therein are not patentable, because they do not represent inventions, but rather mere discoveries.

However, the active principles of these plants will be patentable. Having been isolated by expensive methodology, these active principles will have become medicaments. Many of these active compounds are not used today, because they are entirely unknown to Mankind.

It is important, however, that indigenous populations that hold the knowledge of the healing power of certain plants should also be given benefits resulting from the licenses granted to the patents.

Conclusions

There is a clear line between the good and the evil, drawn by the COMMON SENSE, and this is the line that will guide the ethics in biotechnology.

As shown above, in each statement, be it religious or philosophical, there is always the counterpart that is also true and that guarantees the biodiversity of ideas, of individuals and of the human race.

It is important to preserve this biodiversity with measures in which the COMMON SENSE reigns, rather than the fanatic one-sidedness of some, so that the so-called "globalization" can ultimately serve as the reunion of peoples, rather than the dilution of individualities and countries.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.